APA (7th ed.) Citation

SE, S., K, S., DF, C., C, E., J, P., S, S., . . . EM, E. (2019). Phase 1-2 study of vorinostat (SAHA), cladribine and rituximab (SCR) in relapsed B-cell non-Hodgkin lymphoma and previously untreated mantle cell lymphoma. British journal of haematology, 186(6), 845. https://doi.org/10.1111/bjh.16008

Chicago Style (17th ed.) Citation

SE, Spurgeon, et al. "Phase 1-2 Study of Vorinostat (SAHA), Cladribine and Rituximab (SCR) in Relapsed B-cell Non-Hodgkin Lymphoma and Previously Untreated Mantle Cell Lymphoma." British Journal of Haematology 186, no. 6 (2019): 845. https://doi.org/10.1111/bjh.16008.

MLA (9th ed.) Citation

SE, Spurgeon, et al. "Phase 1-2 Study of Vorinostat (SAHA), Cladribine and Rituximab (SCR) in Relapsed B-cell Non-Hodgkin Lymphoma and Previously Untreated Mantle Cell Lymphoma." British Journal of Haematology, vol. 186, no. 6, 2019, p. 845, https://doi.org/10.1111/bjh.16008.